Logo image of ALESA.PA

ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALESA - FR0011490648 - Common Stock

0.7 EUR
-0.03 (-4.63%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ALESA scores 2 out of 10 in our fundamental rating. ALESA was compared to 44 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of ALESA have multiple concerns. ALESA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALESA has reported negative net income.
In the past year ALESA had a positive cash flow from operations.
In the past 5 years ALESA always reported negative net income.
ALESA had a negative operating cash flow in each of the past 5 years.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

ALESA has a Return On Assets of -12.91%. This is in the lower half of the industry: ALESA underperforms 77.27% of its industry peers.
ALESA has a worse Return On Equity (-76.91%) than 81.82% of its industry peers.
Industry RankSector Rank
ROA -12.91%
ROE -76.91%
ROIC N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

ALESA has a Gross Margin of 64.42%. This is in the better half of the industry: ALESA outperforms 68.18% of its industry peers.
ALESA's Gross Margin has improved in the last couple of years.
ALESA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALESA has about the same amount of shares outstanding.
The number of shares outstanding for ALESA has been increased compared to 5 years ago.
ALESA has a worse debt/assets ratio than last year.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALESA has an Altman-Z score of -1.66. This is a bad value and indicates that ALESA is not financially healthy and even has some risk of bankruptcy.
ALESA has a Altman-Z score of -1.66. This is amonst the worse of the industry: ALESA underperforms 84.09% of its industry peers.
The Debt to FCF ratio of ALESA is 48.08, which is on the high side as it means it would take ALESA, 48.08 years of fcf income to pay off all of its debts.
ALESA has a Debt to FCF ratio of 48.08. This is in the lower half of the industry: ALESA underperforms 63.64% of its industry peers.
ALESA has a Debt/Equity ratio of 3.78. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.78, ALESA is not doing good in the industry: 84.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF 48.08
Altman-Z -1.66
ROIC/WACCN/A
WACCN/A
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALESA has a Current Ratio of 2.76. This indicates that ALESA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.76, ALESA belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
A Quick Ratio of 2.48 indicates that ALESA has no problem at all paying its short term obligations.
The Quick ratio of ALESA (2.48) is better than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.48
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

3. Growth

3.1 Past

ALESA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.51%.
The Revenue has been growing slightly by 4.19% in the past year.
The Revenue has been growing slightly by 5.43% on average over the past years.
EPS 1Y (TTM)5.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.8%
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALESA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 1.37, the valuation of ALESA can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALESA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ALESA to the average of the S&P500 Index (34.46), we can say ALESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.37
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

ALESA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALESA is cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.62
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

ALESA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALESA!.
Industry RankSector Rank
Dividend Yield N/A

ECOSLOPS

EPA:ALESA (11/21/2025, 7:00:00 PM)

0.7

-0.03 (-4.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)10-30 2025-10-30
Earnings (Next)04-28 2026-04-28
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.63M
Revenue(TTM)11.36M
Net Income(TTM)-3.07M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.37
P/S 0.32
P/FCF 10.62
P/OCF 3.02
P/B 0.91
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.51
Fwd EY72.84%
FCF(TTM)0.07
FCFY9.41%
OCF(TTM)0.23
OCFY33.11%
SpS2.19
BVpS0.77
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.91%
ROE -76.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.42%
FCFM 3.01%
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF 48.08
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.76
Quick Ratio 2.48
Altman-Z -1.66
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.8%
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-198.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1271.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y197.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y155.96%
OCF growth 3YN/A
OCF growth 5YN/A

ECOSLOPS / ALESA.PA FAQ

What is the fundamental rating for ALESA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALESA.PA.


Can you provide the valuation status for ECOSLOPS?

ChartMill assigns a valuation rating of 5 / 10 to ECOSLOPS (ALESA.PA). This can be considered as Fairly Valued.


How profitable is ECOSLOPS (ALESA.PA) stock?

ECOSLOPS (ALESA.PA) has a profitability rating of 1 / 10.


What is the financial health of ECOSLOPS (ALESA.PA) stock?

The financial health rating of ECOSLOPS (ALESA.PA) is 3 / 10.